Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$368K Sell
8,579
-81
-0.9% -$3.34K 0.01% 349
2023
Q4
$321K Buy
8,660
+81
+0.9% +$2.91K 0.01% 364
2023
Q3
$311K Hold
8,579
0.01% 336
2023
Q2
$306K Buy
8,579
+463
+6% +$16.6K 0.01% 353
2023
Q1
$289K Sell
8,116
-204
-2% -$7.14K 0.01% 326
2022
Q4
$292K Buy
8,320
+204
+3% +$6.79K 0.01% 336
2022
Q3
$239K Sell
8,116
-81
-1% -$3.07K 0.01% 346
2022
Q2
$446K Buy
+8,197
New +$453K 0.02% 257

Other funds holding GSK

InterOcean Capital Group's GSK Position: Q1 2024 in Review

InterOcean Capital Group reduced its GSK (GSK) stake by 0.94% in Q1 2024, selling an estimated $3.34K and leaving 8,579 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #349.

InterOcean Capital Group first reported a position in GSK in Q2 2022 and has held it in 8 quarters since. The position peaked at $446K in Q2 2022. 911 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • InterOcean Capital Group held 8,579 shares of GSK worth $368K as of Q1 2024.
  • InterOcean Capital Group sold 81 GSK shares in Q1 2024, an estimated $3.34K.
  • GSK made up 0.01% of InterOcean Capital Group's portfolio in Q1 2024, its #349 holding.
  • InterOcean Capital Group first reported a position in GSK in Q2 2022 and has held it in 8 quarters since.
  • InterOcean Capital Group's GSK position peaked at $446K in Q2 2022.
  • 911 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.